HERV-K and LINE-1 DNA methylation and reexpression in urothelial carcinoma

Frontiers in Oncology

Volumn 3 SEP, Issue , 2013, Pages

  Kreimer, Ulrike ^a   Schulz, Wolfgang A ^a   Koch, Annemarie ^a   Niegisch, Günter ^a   Goering, Wolfgang ^a  

^a Department of Orthopedic Surgery   (Germany)

Author keywords

Alu; DNA hypomethylation; HERV K; LINE 1; Retroelements; Urothelial carcinoma

Indexed keywords

HERV K PROTEIN; LINE 1 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CHROMOSOME 1; CHROMOSOME 10; CHROMOSOME 11; CHROMOSOME 12; CHROMOSOME 3; CHROMOSOME 5; DNA METHYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PROTEIN EXPRESSION; PROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSITIONAL CELL CARCINOMA;

EID: 84891139346     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2013.00255     Document Type: Article

References (67)

1. Shen H, Laird PW. Interplay between the cancer genome and epigenome. Cell (2013) 153:38-55. doi: 10.1016/j.cell.2013.03.008
2. Jones PA, Baylin SB. The epigenomics of cancer. Cell (2007) 128:683-92. doi:10.1016/j.cell.2007.01.029
3. Hoffmann MJ, Schulz WA. Causes and consequences of DNA hypomethylation in human cancer. Biochem Cell Biol (2005) 83:296-321. doi:10.1139/o05-036
4. Wilson AS, Power BE, Molloy PL. DNA hypomethylation and human diseases. Biochim Biophys Acta (2007) 1775:138-62.
5. Goodier JL, Kazazian HH Jr. Retrotransposons revisited: the restraint and rehabilitation of parasites. Cell (2008) 135:23-35. doi:10.1016/j.cell.2008.09.022
6. Schulz WA. L1 retrotransposons in human cancers. J Biomed Biotechnol (2006) 2006:83672. doi:10.1155/JBB/2006/83672
7. Goering W, Ribarska T, Schulz WA. Selective changes of retroelement expression in human prostate cancer. Carcinogenesis (2011) 32:1484-92. doi:10.1093/carcin/bgr181
8. Florl AR, Steinhoff C, Muller M, Seifert HH, Hader C, Engers R, et al. Coordinate hypermethylation at specific genes in prostate carcinoma precedes LINE-1 hypomethylation. Br J Cancer (2004) 91:985-94.
9. Florl AR, Lower R, Schmitz-Drager BJ, Schulz WA. DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas. Br J Cancer (1999) 80:1312-21. doi:10.1038/sj.bjc.6690524
10. Wolff EM, Byun HM, Han HF, Sharma S, Nichols PW, Siegmund KD, et al. Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer. PLoS Genet (2010) 6:e1000917. doi:10.1371/journal.pgen.1000917
11. van Bemmel D, Lenz P, Liao LM, Baris D, Sternberg LR, Warner A, et al. Correlation of LINE-1 methylation levels in patient-matched buffy coat, serum, buccal cell, and bladder tumor tissue DNA samples. Cancer Epidemiol Biomarkers Prev (2012) 21:1143-8. doi:10.1158/1055-9965.EPI-11-1030
12. Ishida T, Obata Y, Ohara N, Matsushita H, Sato S, Uenaka A, et al. Identification of the HERV-K gag antigen in prostate cancer by SEREX using autologous patient serum and its immunogenicity. Cancer Immun (2008) 8:15.
13. Tomlins SA, Laxman B, Dhanasekaran SM, Helgeson BE, Cao X, Morris DS, et al. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature (2007) 448:595-9. doi:10.1038/nature06024
14. Hermans KG, Van Der Korput HA, Van Marion R, Van De Wijngaart DJ, Ziel-Van Der Made A, Dits NF, et al. Truncated ETV1, fused to novel tissue-specific genes, and full-length ETV1 in prostate cancer. Cancer Res (2008) 68:7541-9. doi:10.1158/0008-5472.CAN-07-5930
15. Stauffer Y, Theiler G, Sperisen P, Lebedev Y, Jongeneel CV. Digital expression profiles of human endogenous retroviral families in normal and cancerous tissues. Cancer Immun (2004) 4:2.
16. Schiavetti F, Thonnard J, Colau D, Boon T, Coulie PG. A human endogenous retroviral sequence encoding an antigen recognized on melanoma by cytolytic T lymphocytes. Cancer Res (2002) 62:5510-6.
17. Koch A, Hatina J, Rieder H, Seifert HH, Huckenbeck W, Jankowiak F, et al. Discovery of TP53 splice variants in two novel papillary urothelial cancer cell lines. Cell Oncol (Dordr) (2012) 35:243-57. doi:10.1007/s13402-012-0082-8
18. Chapman EJ, Williams SV, Platt FM, Hurst CD, Chambers P, Roberts P, et al. Integrated genomic and transcriptional analysis of the in vitro evolution of telomerase-immortalized urothelial cells (TERT-NHUC). Genes Chromosomes Cancer (2009) 48:694-710. doi:10.1002/gcc.20672
19. Seifert HH, Meyer A, Cronauer MV, Hatina J, Muller M, Rieder H, et al. A new and reliable culture system for superficial low-grade urothelial carcinoma of the bladder. World J Urol (2007) 25:297-302. doi:10.1007/s00345-007-0166-7
20. Swiatkowski S, Seifert HH, Steinhoff C, Prior A, Thievessen I, Schliess F, et al. Activities of MAP-kinase pathways in normal uroepithelial cells and urothelial carcinoma cell lines. Exp Cell Res (2003) 282:48-57. doi:10.1006/excr.2002.5647
21. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res (2001) 29:e45. doi:10.1093/nar/29.9.e45
22. Ogino S, Nosho K, Kirkner GJ, Kawasaki T, Chan AT, Schernhammer ES, et al. A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer. J Natl Cancer Inst (2008) 100:1734-8. doi:10.1093/jnci/djn359
23. Yegnasubramanian S, Haffner MC, Zhang Y, Gurel B, Cornish TC, Wu Z, et al. DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity. Cancer Res (2008) 68:8954-67. doi:10.1158/0008-5472.CAN-07-6088
24. Baba Y, Huttenhower C, Nosho K, Tanaka N, Shima K, Hazra A, et al. Epigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors. Mol Cancer (2010) 9:125. doi:10.1186/1476-4598-9-125
25. Belancio VP, Roy-Engel AM, Pochampally RR, Deininger P. Somatic expression of LINE-1 elements in human tissues. Nucleic Acids Res (2010) 38:3909-22. doi:10.1093/nar/gkq132
26. Cruickshanks HA, Tufarelli C. Isolation of cancer-specific chimeric transcripts induced by hypomethylation of the LINE-1 antisense promoter. Genomics (2009) 94:397-406. doi:10.1016/j.ygeno.2009.08.013
27. Speek M. Antisense promoter of human L1 retrotransposon drives transcription of adjacent cellular genes. Mol Cell Biol (2001) 21:1973-85. doi:10.1128/MCB.21.6.1973-1985.2001
28. Schulz WA. Understanding urothelial carcinoma through cancer pathways. Int J Cancer (2006) 119:1513-8. doi:10.1002/ijc.21852
29. Haoudi A, Semmes OJ, Mason JM, Cannon RE. Retrotransposition-competent human LINE-1 induces apoptosis in cancer cells with intact p53. J Biomed Biotechnol (2004) 2004:185-94. doi:10.1155/S1110724304403131
30. Harris CR, Dewan A, Zupnick A, Normart R, Gabriel A, Prives C, et al. p53 responsive elements in human retrotransposons. Oncogene (2009) 28:3857-65. doi:10.1038/onc.2009.246
31. Moran JV, Holmes SE, Naas TP, Deberardinis RJ, Boeke JD, Kazazian HH Jr. High frequency retrotransposition in cultured mammalian cells. Cell (1996) 87:917-27. doi:10.1016/S0092-8674(00)81998-4
32. Evans JD, Peddigari S, Chaurasiya KR, Williams MC, Martin SL. Paired mutations abolish and restore the balanced annealing and melting activities of ORF1p that are required for LINE-1 retrotransposition. Nucleic Acids Res (2011) 39:5611-21. doi:10.1093/nar/gkr171
33. Hancks DC, Kazazian HH Jr. Active human retrotransposons: variation and disease. Curr Opin Genet Dev (2012) 22:191-203. doi:10.1016/j.gde.2012.02.006
34. Iskow RC, McCabe MT, Mills RE, Torene S, Pittard WS, Neuwald AF, et al. Natural mutagenesis of human genomes by endogenous retrotransposons. Cell (2010) 141:1253-61. doi:10.1016/j.cell.2010.05.020
35. Lee E, Iskow R, Yang L, Gokcumen O, Haseley P, Luquette LJ III, et al. Landscape of somatic retrotransposition in human cancers. Science (2012) 337:967-71. doi:10.1126/science.1222077
36. Solyom S, Ewing AD, Hancks DC, Takeshima Y, Awano H, Matsuo M, et al. Pathogenic orphan transduction created by a nonreference LINE-1 retrotransposon. Hum Mutat (2012) 33:369-71. doi:10.1002/humu.21663
37. Shukla R, Upton KR, Munoz-Lopez M, Gerhardt DJ, Fisher ME, Nguyen T, et al. Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinoma. Cell (2013) 153:101-11. doi:10.1016/j.cell.2013.02.032
38. Flockerzi A, Ruggieri A, Frank O, Sauter M, Maldener E, Kopper B, et al. Expression patterns of transcribed human endogenous retrovirus HERV-K(HML-2) loci in human tissues and the need for a HERV Transcriptome Project. BMC Genomics (2008) 9:354. doi:10.1186/1471-2164-9-354
39. Wang-Johanning F, Radvanyi L, Rycaj K, Plummer JB, Yan P, Sastry KJ, et al. Human endogenous retrovirus K triggers an antigen-specific immune response in breast cancer patients. Cancer Res (2008) 68:5869-77. doi:10.1158/0008-5472.CAN-07-6838
40. Nellaker C, Li F, Uhrzander F, Tyrcha J, Karlsson H. Expression profiling of repetitive elements by melting temperature analysis: variation in HERV-W gag expression across human individuals and tissues. BMC Genomics (2009) 10:532. doi:10.1186/1471-2164-10-532
41. Wang-Johanning F, Rycaj K, Plummer JB, Li M, Yin B, Frerich K, et al. Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors. J Natl Cancer Inst (2012) 104:189-210. doi:10.1093/jnci/djr540
42. Turner G, Barbulescu M, Su M, Jensen-Seaman MI, Kidd KK, Lenz J. Insertional polymorphisms of full-length endogenous retroviruses in humans. Curr Biol (2001) 11:1531-5. doi:10.1016/S0960-9822(01)00455-9
43. Moyes DL, Martin A, Sawcer S, Temperton N, Worthington J, Griffiths DJ, et al. The distribution of the endogenous retroviruses HERV-K113 and HERV-K115 in health and disease. Genomics (2005) 86:337-41. doi:10.1016/j.ygeno.2005.06.004
44. Moyes DL, Goris A, Ban M, Compston A, Griffiths DJ, Sawcer S, et al. HERV-K113 is not associated with multiple sclerosis in a large family-based study. AIDS Res Hum Retroviruses (2008) 24:363-5. doi:10.1089/aid.2007.0196
45. Catto JW, Yates DR, Rehman I, Azzouzi AR, Patterson J, Sibony M, et al. Behavior of urothelial carcinoma with respect to anatomical location. J Urol (2007) 177:1715-20. doi:10.1016/j.juro.2007.01.030
46. Waliszewski P, Waliszewska MK, Hemstreet GP III, Hurst RE. Expression of sex steroid receptor genes and comodulation with retinoid signaling in normal human uroepithelial cells and bladder cancer cell lines. Urol Oncol (1997) 3:141-7. doi:10.1016/S1078-1439(98)00011-8
47. Kiriluk KJ, Prasad SM, Patel AR, Steinberg GD, Smith ND. Bladder cancer risk from occupational and environmental exposures. Urol Oncol (2012) 30:199-211. doi:10.1016/j.urolonc.2011.10.010
48. Brait M, Munari E, Lebron C, Noordhuis MG, Begum S, Michailidi C, et al. Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma. Cell Cycle (2013) 12:1058-70. doi:10.4161/cc.24050
49. Gabriel U, Steidler A, Trojan L, Michel MS, Seifarth W, Fabarius A. Smoking increases transcription of human endogenous retroviruses in a newly established in vitro cell model and in normal urothelium. AIDS Res Hum Retroviruses (2010) 26:883-8. doi:10.1089/aid.2010.0014
50. Christensen T. HERVs in neuropathogenesis. J Neuroimmune Pharmacol (2010) 5:326-35. doi:10.1007/s11481-010-9214-y
51. Fuchs NV, Kraft M, Tondera C, Hanschmann KM, Lower J, Lower R. Expression of the human endogenous retrovirus (HERV) group HML-2/HERV-K does not depend on canonical promoter elements but is regulated by transcription factors Sp1 and Sp3. J Virol (2011) 85:3436-48. doi:10.1128/JVI.02539-10
52. Katoh I, Mirova A, Kurata S, Murakami Y, Horikawa K, Nakakuki N, et al. Activation of the long terminal repeat of human endogenous retrovirus K by melanoma-specific transcription factor MITF-M. Neoplasia (2011) 13:1081-92.
53. Gonzalez-Hernandez MJ, Swanson MD, Contreras-Galindo R, Cookinham S, King SR, Noel RJ Jr, et al. Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1. J Virol (2012) 86:7790-805. doi:10.1128/JVI.07215-11
54. Nikitina TV, Tischenko LI, Schulz WA. Recent insights into regulation of transcription by RNA polymerase III and the cellular functions of its transcripts. Biol Chem (2011) 392:395-404. doi:10.1515/BC.2011.049
55. Fornace AJ Jr, Mitchell JB. Induction of B2 RNA polymerase III transcription by heat shock: enrichment for heat shock induced sequences in rodent cells by hybridization subtraction. Nucleic Acids Res (1986) 14:5793-811. doi:10.1093/nar/14.14.5793
56. Li TH, Schmid CW. Differential stress induction of individual Alu loci: implications for transcription and retrotransposition. Gene (2001) 276:135-41. doi:10.1016/S0378-1119(01)00637-0
57. Mariner PD, Walters RD, Espinoza CA, Drullinger LF, Wagner SD, Kugel JF, et al. Human Alu RNA is a modular transacting repressor of mRNA transcription during heat shock. Mol Cell (2008) 29:499-509. doi:10.1016/j.molcel.2007.12.013
58. Ernens I, Goodfellow SJ, Innes F, Kenneth NS, Derblay LE, White RJ, et al. Hypoxic stress suppresses RNA polymerase III recruitment and tRNA gene transcription in cardiomyocytes. Nucleic Acids Res (2006) 34:286-94. doi:10.1093/nar/gkj402
59. Pal A, Srivastava T, Sharma MK, Mehndiratta M, Das P, Sinha S, et al. Aberrant methylation and associated transcriptional mobilization of Alu elements contributes to genomic instability in hypoxia. J Cell Mol Med (2010) 14:2646-54. doi:10.1111/j.1582-4934.2009.00792.x
60. Ord JJ, Streeter EH, Roberts IS, Cranston D, Harris AL. Comparison of hypoxia transcriptome in vitro with in vivo gene expression in human bladder cancer. Br J Cancer (2005) 93:346-54. doi:10.1038/sj.bjc.6602666
61. Batzer MA, Deininger PL. Alu repeats and human genomic diversity. Nat Rev Genet (2002) 3:370-9. doi:10.1038/nrg798
62. Xie H, Wang M, Bonaldo Mde F, Smith C, Rajaram V, Goldman S, et al. High-throughput sequence-based epigenomic analysis of Alu repeats in human cerebellum. Nucleic Acids Res (2009) 37:4331-40. doi:10.1093/nar/gkp393
63. Daskalos A, Nikolaidis G, Xinarianos G, Savvari P, Cassidy A, Zakopoulou R, et al. Hypomethylation of retrotransposable elements correlates with genomic instability in non-small cell lung cancer. Int J Cancer (2009) 124:81-7. doi:10.1002/ijc.23849
64. Szpakowski S, Sun X, Lage JM, Dyer A, Rubinstein J, Kowalski D, et al. Loss of epigenetic silencing in tumors preferentially affects primate-specific retroelements. Gene (2009) 448:151-67. doi:10.1016/j.gene.2009.08.006
65. Cho YH, Yazici H, Wu HC, Terry MB, Gonzalez K, Qu M, et al. Aberrant promoter hypermethylation and genomic hypomethylation in tumor, adjacent normal tissues and blood from breast cancer patients. Anticancer Res (2010) 30:2489-96.
66. Xiang S, Liu Z, Zhang B, Zhou J, Zhu BD, Ji J, et al. Methylation status of individual CpG sites within Alu elements in the human genome and Alu hypomethylation in gastric carcinomas. BMC Cancer (2010) 10:44. doi:10.1186/1471-2407-10-44
67. Xie H, Wang M, De Andrade A, Bonaldo Mde F, Galat V, Arndt K, et al. Genome-wide quantitative assessment of variation in DNA methylation patterns. Nucleic Acids Res (2011) 39:4099-108. doi:10.1093/nar/gkr017